Gene Patenting Web Quest Law Meets Bioethics Katie Horne Marshfield High School Biology.

Slides:



Advertisements
Similar presentations
Ethical aspects and Patents in Lifescience Peter R. Thomsen Manager Global IP Litigation, Corporate Intellectual Property, Novartis WIPO symposium on IP.
Advertisements

Intellectual Property Patents Designs Copyright Trademarks.
WIPO/INV/BEI/02/18 SECOND INTERNATIONAL FORUM ON CREATIVITY AND INVENTION – A BETTER FUTURE FOR HUMANITY IN THE 21 ST CENTURY Beijing (China), May 23-25,
How Can You Patent Genes? Margaret Everett PSU. What are patents? b Exclusive rights to an invention b fixed period of time.
Patenting Life and University-Industry Relations HSCI E137 Mar 2, 2011 Announcement: Debate lists are now posted. Let me know by Fri Mar 4 if you do NOT.
Intellectual Property
Ownership and distribution Ethical issues in patenting Pr Samia Hurst Institute for Biomedical Ethics University of Geneva Medical School.
Bioethics Case Studies Patenting Genes. What is a patent? A patent gives an inventor the right for a limited period to stop others from making, using.
CONFIDENTIAL PATENTS What You Need To Know Robert Benson Office of Technology Development Harvard University Brandeis University – October 20, 2005.
© 2006 McGraw-Hill Ryerson Limited. All rights reserved.1 Chapter 11: Monopoly Prepared by: Kevin Richter, Douglas College Charlene Richter, British Columbia.
Intellectual property Rights in Immunological Bioinformatics Ole Lund, CBS, BioCentrum, DTU.
P A R T P A R T Crimes & Torts Crimes Intentional Torts Negligence & Strict Liability Intellectual Property & Unfair Competition 2 McGraw-Hill/Irwin Business.
Chapter 5 Intellectual Property & Internet Law
Prometheus & Myriad The Future of Diagnostic & Gene Claims Mercedes Meyer, Ph.D. Kevin Noonan, Ph.D.
Patents and trade secrets 6 6 Chapter. Patents  Grant of property rights to inventors  Issued by the U.S. Patent and Trademark Office (USPTO)  Permits.
Thinking of Studying Biological Sciences? Dr Amrit Mudher Lecturer in Neurosciences School of Biological Sciences University of Southampton
Arabidopsis Gene Project GK-12 April Workshop Karolyn Giang and Dr. Mulligan.
EPIP 2 Research Tools in Genetics Sandy Thomas Nuffield Council on Bioethics November 2003.
Meanwhile in Europe: HGS Inc v Eli Lilly & co The industrial application test for novel proteins: All in the family? AIPLA Biotech committee meeting 25.
The Case of Myriad Genetics (Vs. an array of National Government Funded European Union Research Institutes) Amir Zaher UC Berkeley, Senior Department of.
A2 Technology Product Design Systems and Control Notes DT4 - Exam.
LO: Be able to describe what gene therapy is and how it could be used.
LESSON 4: PowerPoint slides to accompany Using Bioinformatics: Genetic Testing.
__________________________ Genetic screening: to identify those with an increased risk of inheriting a disorder Often tied to ethnic background May involve.
LEQ: WHAT ARE THE BENEFITS OF DNA TECHNOLOGY & THE HUMAN GENOME PROJECT? to
Public Policy Considerations and Patent Eligible Subject Matter Relating to Diagnostic Inventions Disclaimer: Any views expressed here are offered in order.
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
Page 1 IOP Genomics Workshop Patents and Patenting Biotech Inventions Annemieke Breukink, Ph.D. September 8th, 2009.
Introduction to IP Ellen Monson Director Intellectual Property Office University of Cincinnati.
Protection of creative, new ideas in any field i.e. design, music, art or elsewhere. Confidentiality Agreement (the oldest form of IPP) Trademark Patent.
Intellectual Property, Patents & Technology Transfer Sagar Manoli Shashidhar, Philippe Abdel-Sayed Responsible Conduct in Biomedical Research EPFL,
Date: April 14, 2011 Topic: Regulation and Deregulation Aim: How does the government protect and promote competition? Do Now: Read the article. Read the.
Introduction to Patents Anatomy of a Patent & Procedures for Getting a Patent Margaret Hartnett Commercialisation & IP Manager University.
John M. Simpson Stem Cell Project Director Foundation for Taxpayer and Consumer Rights Tel: URL:
Access to Genetic Resources & Traditional Knowledge The Bellagio compulsory cross-licensing proposal for benefit sharing consistent with more competition.
Patents Business of Biotechnology BIT 120. Definition Patent Government grants which provide inventors with right to exclude others from practicing invention.
The Human Genome Project & Pedigrees Chapter 11 & 12.
How Commercial Firms Protect Intellectual Property In Transactions Daniel J. Mazella Celera Genomics Group, An Applera Corporation Business.
© 2011 Dannemann Siemsen. Todos os direitos reservados. Biotech IP issues in Brazil Gustavo Morais May 2011 Gustavo Morais May 2011.
A: Copy –Rights – Artistic, Literary work, Computer software Etc. B: Related Rights – Performers, Phonogram Producers, Broadcasters etc. C: Industrial.
Monopolies!!! Are they good for society?. Monopoly Characteristics: 1. Number of Firms = 1 2. Variety of Goods = None 3. Barriers to Entry = Complete.
Industry and Academia cooperation in Finland Michał Joachimiak.
Gene Mapping ROBERT SANTOS ENGLISH 100 ESP NOVEMBER
What is... Gene Therapy?. Genes Specific sequence of bases that encode instructions on how to make genes. Genes are passed on from parent to child. When.
Meet the Gene Machine Basic Genetics & Background on Genetic Testing.
Patent Innovation Christine Chen 9/15/2008.  In general, patents must be:  Novel (not known previously) genetic sequences  Non-obvious (not just a.
Biotechnology and Bioinformatics: Bioinformatics Essential Idea: Bioinformatics is the use of computers to analyze sequence data in biological research.
Gene Technologies and Human ApplicationsSection 1 Section 1: The Human Genome Preview Bellringer Key Ideas Secrets of the Human Genome Applications of.
IP and the working archive Issues arising from the use of Mass Observation Elizabeth Dunn Gaby Hardwicke - Solicitors & Trade Mark Attorneys.
Introduction The Patentability of Human Genes Is patenting human genes moral? Should it be legal? Should there be international intervention?
Patent Review Overview Summary of different types of Intellectual Property What is a patent? Why would you want one? What are the requirements for patentability?
VISHAAL HARISARAN Intellectual Property Rights in Animal Breeding and Genetics.
Be Safe: when experimenting and disposing of waste.
Technology Transfer Office
Bridging the Gap Workshop
Intellectual Property & Contemporary Issues of Biotechnology Law
© 2005 The McGraw-Hill Companies, Inc. All rights reserved.
IP-INITIAL® द्वारा प्रस्तुत IP-INITIAL®
The Challenge of Biotech Patent Eligibility in the United States:
Technology Management Activities and Tools
Chapter 06: LEGAL ISSUES FOR THE ENTREPRENEUR
SOCIAL,ETHICAL AND LEGAL IMPLICATIONS OF BIOTECHNOLOGY
What is ... Gene Therapy?.
Basic Genetics & Background on Genetic Testing
Role of IP in facilitating the transfer of technology
The Future of Genetic Research
What is Biomedical Research?
Gene Patenting Connecticut Invention Convention
Presentation transcript:

Gene Patenting Web Quest Law Meets Bioethics Katie Horne Marshfield High School Biology

Gene Patents and Immunology?? Aspects of immunology embedded in another topic. Aspects of immunology embedded in another topic. Gene Patenting is a new development. Gene Patenting is a new development. Student enthusiasm. Student enthusiasm.

The Cases John Moore and his amazing spleen John Moore and his amazing spleen Erich Fuchs and Steve Crohn: HIV immunity and the plague connection Erich Fuchs and Steve Crohn: HIV immunity and the plague connection Daniel Greenberg and the tragedy of Canavan Disease Daniel Greenberg and the tragedy of Canavan Disease The Terry’s get smart when it comes to patent law The Terry’s get smart when it comes to patent law The (unfair?) treatment of Arupa Ganguly, PhD. The (unfair?) treatment of Arupa Ganguly, PhD.

John Moore and His Amazing Spleen The diagnosis The diagnosis Dr. Golde takes a special interest Dr. Golde takes a special interest The Biotech companies jump in The Biotech companies jump in Where does that leave Mr. Moore? Where does that leave Mr. Moore?

HIV “Immunity” Erich Fuchs and Steve Crohn are born lucky Erich Fuchs and Steve Crohn are born lucky The Aaron Diamond Institute The Aaron Diamond Institute CCR5 delta 32 CCR5 delta 32 People with European descent are more likely to have CCR5 delta 32 People with European descent are more likely to have CCR5 delta 32

The Tragedy of the Greenbergs Diagnosis: Canavan Disease Diagnosis: Canavan Disease Tissue samples, recruited patients, $$$ Tissue samples, recruited patients, $$$

The Foresight of the Terry’s Diagnosis: Pseudoxanthoma elasticum Diagnosis: Pseudoxanthoma elasticum Tissue samples, recruited patients, $$$, AND A Signed Contract! Tissue samples, recruited patients, $$$, AND A Signed Contract!

Arupa Ganguly, PhD. BRCA 1 and 2 Testing BRCA 1 and 2 Testing Myriad Genetics Myriad Genetics Winners: Myriad Losers: The public? Winners: Myriad Losers: The public?

The Law The role of patents in research The role of patents in research Rules of the genetic game Rules of the genetic game 20 year monopoly 20 year monopoly

PRO: Researchers are rewarded for their discoveries and can use monies gained from patenting to further their research. The investment of resources is encouraged by providing a monopoly to the inventor and prohibiting competitors from making, using, or selling the invention without a license. Wasteful duplication of effort is prevented. Research is forced into new, unexplored areas. Secrecy is reduced and all researchers are ensured access to the new invention CON: Patents of partial and uncharacterized cDNA sequences will reward those who make routine discoveries but penalize those who determine biological function or application (inappropriate reward given to the easiest step in the process). Patents could impede the development of diagnostics and therapeutics by third parties because of the costs associated with using patented research data. Patent stacking (allowing a single genomic sequence to be patented in several ways such as an EST, a gene, and a SNP) may discourage product development because of high royalty costs owed to all patent owners of that sequence; these are costs that will likely be passed on to the consumer. Because patent applications remain secret until granted, companies may work on developing a product only to find that new patents have been granted along the way, with unexpected licensing costs and possible infringement penalties. Costs increase not only for paying for patent licensing but also for determining what patents apply and who has rights to downstream products. Patent holders are being allowed to patent a part of nature --a basic constituent of life; this allows one organism to own all or part of another organism. Private biotechs who own certain patents can monopolize certain gene test markets. Patent filings are replacing journal articles as places for public disclosure --reducing the body of knowledge in the literature.

Bioinformatics The ABC’s The ABC’s HIV and the CCR5 delta 32 mutation HIV and the CCR5 delta 32 mutation Using NCBI, find the nucleotide difference Using NCBI, find the nucleotide difference Special thanks to Dave Form Special thanks to Dave Form

The Actual Patents htm htm htm htm htm htm htm htm

Additional Resources Do Your Cells Belong to You? Do Your Cells Belong to You? To Own or Not to Own DNA To Own or Not to Own DNA